Use of teicoplanin monotherapy for the treatment of enterococcal infective endocarditis: a retrospective and comparative study at a referral centre
Journal of Antimicrobial Chemotherapy · 2024
DOI: 10.1093/jac/dkae291 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Miguel Villamarín und 5 weiteren Autor:innen. Beteiligte Einrichtung: Servei de Malalties Infeccioses, Hospital Universitari Vall d'Hebron, Barcelona, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Ca…. Hauptthemen laut MEDLINE: Teicoplanin, Anti-Bacterial Agents, Gram-Positive Bacterial Infections, Endocarditis, Bacterial. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Objectives
Clinical experience in the use of teicoplanin for treating enterococcal infective endocarditis (EIE) is scarce. The aim of this study was to describe the characteristics and outcomes of patients with EIE treated with teicoplanin monotherapy compared to standard therapy with ampicillin plus ceftriaxone.
Methods
All consecutive adult patients diagnosed with EIE between January 2018 and September 2022 at a referral centre were reviewed. Characteristics of individuals treated with teicoplanin for ≥14 days [the treated with teicoplanin (TT) group] were compared with those who received ampicillin plus ceftriaxone (AC group).
Results
Sixty-six patients were included [61 (92%) E. faecalis infective endocarditis (IE) and 5 (8%) E. faecium IE]. Twenty-seven (41%) received teicoplanin: eight as first-line treatment and 19 as continuation therapy. The median duration of teicoplanin treatment was 30 (25–43) days. Surgery was indicated in 14/27 (52%) in the TT group and in 21/39 (54%) in the AC group, but was finally performed in 11/14 (79%) and 13/21 (62%) (P = 0.46), respectively. In-hospital mortality rate was 3/27 (11%) in the TT group and 12/39 (31%) in the AC group (P = 0.06). Patients treated with teicoplanin were more often discharged on outpatient parenteral antibiotic therapy [18/27 (67%) versus 6/39 (15%), P < 0.001] and median hospital stay was shorter [29 days (IQR 20–61) versus 50 days (IQR 43–68), P = 0.006]. One-year cumulative mortality was 8/27 (30%) in the TT group and 13/39 (33%) in the AC group (P = 0.46). There was one relapse in each group.
Conclusion
Teicoplanin seems an effective treatment for selected patients with enterococcal IE, mainly to facilitate discharge.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Servei de Malalties Infeccioses, Hospital Universitari Vall d'Hebron, Barcelona, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Campus Hospitalari, Passeig de la Vall d'Hebron 119-129, Barcelona 08035…
- Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.
- CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
- Servei de Microbiologia, Hospital Universitari Vall d'Hebron, Barcelona, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Campus Hospitalari, Passeig de la Vall d'Hebron 119-129, Barcelona 08035, Spain.
- Departament de Genètica i Microbiologia, Universitat Autònoma de Barcelona, Barcelona, Spain.
- Servei de Cardiologia, Hospital Universitari Vall d'Hebron, Barcelona, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Campus Hospitalari, Passeig de la Vall d'Hebron 119-129, Barcelona 08035, Spain.
ORCID-Profile: Miguel Villamarín, Nuria Fernández-Hidalgo, Juan José González-López, Pau Rello, Laura Escolà-Vergé
Zitieren
APA
Villamarín, M., Fernández-Hidalgo, N., Viñado, B., González-López, J. J., Rello, P., & Escolà-Vergé, L. (2024). Use of teicoplanin monotherapy for the treatment of enterococcal infective endocarditis: a retrospective and comparative study at a referral centre. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae291
Vancouver
Villamarín M, Fernández-Hidalgo N, Viñado B, González-López JJ, Rello P, Escolà-Vergé L. Use of teicoplanin monotherapy for the treatment of enterococcal infective endocarditis: a retrospective and comparative study at a referral centre. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae291
BibTeX
@article{Villamarn2024,
author = {Villamarín, Miguel and Fernández-Hidalgo, Nuria and Viñado, Belén and González-López, Juan José and Rello, Pau and Escolà-Vergé, Laura},
title = {Use of teicoplanin monotherapy for the treatment of enterococcal infective endocarditis: a retrospective and comparative study at a referral centre},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2024},
doi = {10.1093/jac/dkae291}
}
EUVIMED